Bristol Myers Squibb Myeloma Trials
Hi, we're SparkCures. We've partnered with Bristol Myers Squibb to help your patients find and connect with clinical trials from around the US.
Featured Clinical Trials
Learn more about the Quintessential trial for patients with relapsed/refractory multiple myeloma who have received 3 or more prior lines of therapy.
Learn more about the Successor-1 trial for patients with relapsed/refractory multiple myeloma who have received 1-3 prior lines of therapy.
Learn more about the Successor-2 trial for patients with relapsed/refractory multiple myeloma who have received one prior line of therapy.
Learn more about the Excaliber RRMM trial for patients with relapsed/refractory multiple myeloma who have received 1-2 prior lines of therapy.
Quickly Find Eligible Clinical Trials
Use our quick screen buttons below to find eligible BMS clinical trials wherever your patients may be.
Newly Diagnosed
Myeloma patients who are untreated / newly diagnosed.1-2 Prior Lines
Myeloma patients with 1 to 2 prior lines of therapy.3+ Prior Lines
Myeloma patients with 3 or more lines of therapy.3+ Lines (BCMA)
Myeloma patients with 3 or more lines of therapy and BCMA therapyCELMoD Trials
View all CELMoD clinical trials from around the USView All Trials
View all myeloma trials sponsored by BMS
Explore Trials by Centers
There are over 100 centers around the US participating in BMS sponsored myeloma clinical trials. Use the links below to explore clinical trials by centers.
About Us
At SparkCures we help myeloma patients and healthcare professionals find, understand and connect with eligible clinical trials from around the US.
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.
For Healthcare Professionals Only
This site includes BMS sponsored trials only. If you are a healthcare professional, you can create a free account with SparkCures Pro to easily search and explore all active myeloma clinical trials around the US.